Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients with Hypertrophic Cardiomyopathy: A Nationwide Cohort Study.
CONCLUSIONS: Compared with warfarin, patients with HCM and AF on NOACs had similar stroke and major bleeding risks, but lower all-cause mortality and composite fatal cardiovascular events. Our data suggest that patients with HCM and AF can be safely and effectively treated with NOACs.
PMID: 30472021 [PubMed - as supplied by publisher]
Source: Chest - Category: Respiratory Medicine Authors: Jung H, Yang PS, Jang E, Yu HT, Kim TH, Uhm JS, Kim JY, Pak HN, Lee MH, Joung B, Lip GYH Tags: Chest Source Type: research
More News: Atrial Fibrillation | Bleeding | Cardiology | Cardiomyopathy | Cardiovascular | Coumadin | Databases & Libraries | Health Insurance | Heart | Hypertrophic Cardiomyopathy | Insurance | Ischemic Stroke | Stroke | Study | Vitamin K | Vitamins | Warfarin
MedWorm Privacy Policy
Disclaimer
Copyright © MedWorm 2006-2024